Extrawell Pharmaceutical Holdings Limited (HK:0858) has released an update.
Extrawell Pharmaceutical Holdings Limited reported a significant annual loss for the fiscal year ending March 31, 2024, with a net loss of HK$161.64 million compared to the previous year’s profit of HK$129.77 million. The loss was attributed to substantial other losses and a decrease in revenue from HK$72.58 million to HK$59.1 million. Additionally, the company experienced a loss per share of HK$6.82, a stark contrast from the earnings of HK$5.41 per share in the prior year.
For further insights into HK:0858 stock, check out TipRanks’ Stock Analysis page.
